An experimental Alzheimer's drug significantly slowed cognitive decline in a large trial of patients in early stages of the disease, companies Eisai and Biogen say https://t.co/yraXOt1cOo https://t.co/yraXOt1cOo— Reuters (@Reuters) September 27, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


